Hypercalcemia suppresses the release of PTH and thus the production of 1,25-dihydroxyvitamin D. However, in some tumor types, 25-dihydroxyvitamin D is produced extrarenally from 25-hydroxyvitamin D, independent of PTH control (19). Here, PTH is linked to hypercalcemia disease.